Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Portfolio Pulse from Avi Kapoor
Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round,' highlighting several companies. He recommended buying Lowe’s Companies, Inc. (LOW) ahead of the Federal Reserve's rate cut cycle and expressed positive views on Blackstone Inc. (BX) and Marvell Technology, Inc. (MRVL). He suggested selling Joby Aviation, Inc. (JOBY) and swapping Edwards Lifesciences Corporation (EW) for Boston Scientific (BSX). Cramer also preferred Schlumberger NV (SLB) over Borr Drilling Limited (BORR) and Abbott (ABT) over DexCom, Inc. (DXCM).
July 31, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer prefers Boston Scientific (BSX) over Edwards Lifesciences (EW).
Cramer's preference for BSX over EW may generate positive sentiment and buying interest in BSX.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Jim Cramer likes Blackstone Inc. (BX) due to its strong portfolio of companies.
Cramer's positive view on BX, combined with its recent earnings beat, is likely to support the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommends buying Lowe’s Companies, Inc. (LOW) ahead of the Federal Reserve's rate cut cycle.
Cramer's recommendation to buy LOW ahead of the Fed rate cut cycle is likely to generate positive sentiment and buying interest in the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Jim Cramer believes Marvell Technology, Inc. (MRVL) is a good stock to own despite recent price decline.
Cramer's confidence in MRVL's management and recent product introduction may help stabilize and potentially boost the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Jim Cramer prefers Schlumberger NV (SLB) over Borr Drilling Limited (BORR).
Cramer's preference for SLB over BORR may lead to increased buying interest in SLB.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Jim Cramer criticizes DexCom, Inc. (DXCM) and prefers Abbott (ABT).
Cramer's negative view on DXCM, combined with its recent weak earnings, may lead to selling pressure on the stock.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Jim Cramer suggests swapping Edwards Lifesciences Corporation (EW) for Boston Scientific (BSX).
Cramer's preference for BSX over EW, combined with EW's recent weak earnings, may negatively impact EW's stock price.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Jim Cramer recommends selling Joby Aviation, Inc. (JOBY).
Cramer's recommendation to sell JOBY may lead to increased selling pressure on the stock.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60